Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture  by Teasdale, Jack E. et al.
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Background:  It is generally  acknowledged  that  e-cigarettes  are  unlikely  to be as  harmful  as  conventional
cigarettes,  but  there  is  little  data  that  quantiﬁes  their  relative  harms.  We  investigated  the  biological
response  to e-cigarette  aerosol  exposure  (versus  conventional  cigarette  smoke  exposure)  at  the  cel-
lular level,  by  exposing  human  coronary  artery  endothelial  cells  (HCAEC)  to aqueous  ﬁltered  extracts
of  e-cigarette  aerosol  or cigarette  smoke  and looking  at gene  expression  changes  consistent  with  a
stress  response.  This  included  genes  controlled  by  the  oxidant-stress  sensing  transcription  factor  NFR2
(NFE2L2),  and cytochrome  P450  family  members.
Methods: Cigarette  smoke  extract  (CSE)  was  created  using  mainstream  smoke  from  a  single  cigarette
drawn  through  10 ml  of  endothelial  cell  growth  media  MV2.  Electronic  cigarette  aerosol  extract  (eCAE)
was created  using  the  same  apparatus,  using  a  constant  power  output  of  10.8  w  (4.2  V)  and  18 mg/ml
nicotine  solution.  eCAE  was  generated  using  5 cycles  of 5 s heat  with  at least  10  s in  between  each  puff
to  allow  the  coil  to cool,  air being  drawn  through  the  device  at  70 ml/minute.
Results:  HCAEC  responded  to the noxious  components  in  CSE,  resulting  in  activation  of  NRF2  and  upreg-
ulation  of  cytochrome  p450.  However,  eCAE  did  not  induce  NRF2  nuclear  localisation,  upregulation  of
NRF2-activated  genes,  or the  upregulation  of  cytochrome  p450.
Conclusions:  The  use of  e-cigarettes  as  a substitute  for conventional  cigarettes  is  likely  to reduce  imme-
diate  tobacco-related  harm,  at least  with  respect  to cardiovascular  harms.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY. Introduction
The rapid growth in the use of e-cigarettes, which deliver nico-
ine via inhaled aerosol rather than tobacco smoke, has generated
ebate regarding their potential beneﬁts relative to conventional
igarettes. While e-cigarettes are unlikely to be as harmful as con-
entional cigarettes, there is little data that quantiﬁes their likely
elative harms, and data does not yet exist on the correlates of
ong-term e-cigarette use. Given this, the development of labo-
atory models that quantify the biological effects, and therefore
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likely relative harms, of e-cigarettes and conventional cigarettes is
critical.
The levels of chemicals known to be harmful present in e-
cigarette aerosol depend on several variables such as the solution
used and the battery output voltage (Bahl et al., 2012; Kosmider
et al., 2014). Critically, a number of these experiments have been
performed with diluted reﬁll solutions (e-liquid), rather than
heated aerosol (Bahl et al., 2012). The levels of toxic product will
depend on the way  the e-cigarette is used (Farsalinos et al., 2015).
Moreover, the mere presence of detectable levels of potentially
harmful chemicals does not necessarily indicate that e-cigarette
aerosol will deliver concentrations required for the chemical to be
toxic. In the absence of long-term prospective data on the health
correlates of e-cigarette use, there is a need to investigate the
potential harmful effects of e-cigarette use. One valuable approach
might be to examine the biological response of human primary cells
to e-cigarette aerosol.
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. CSE but not eCAE or nicotine increase NRF2-regulated gene expression.
Panel A) Fold change of mRNA expression levels of heme oxygenase 1 (HMOX1), oxidative stress growth inhibitor 1 (OSGIN1), glutamate-cysteine ligase (GCLM) and protease
activated receptor 4 (PAR4–from F2RL3 gene), exposed to 3 sequential treatments of CSE (10%), eCAE (10%) or nicotine (350 ng/ml, 2.16 M), or vehicle control (*P < 0.05 v
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lll  other treatments, n = 4–6). Panel B) Cellular localisation of NRF2 as assessed by i
redominantly nuclear localisation, co-localising with the nuclear blue dapi stainin
upplementary Table 2.
The oxidant-stress sensing transcription factor NFR2 (nuclear
actor, erythroid 2-like 2, NFE2L2) is normally sequestered in the
ytoplasm through interaction with kelch-like ECH-associated pro-
ein 1 (KEAP1), but this interaction is disrupted upon electrophilic
ttack, allowing NFR2 to translocate to the nucleus and activate
ene expression (Müller and Hengstermann, 2012). As such, activa-
ion of the NRF2 system is a useful cellular biomarker of biologically
elevant levels of free radicals. Combustion products of tobacco
ctivate NFR2-regulated gene expression in the lung and initi-
te a transcription proﬁle that contributes to protection from the
tress induced by tobacco smoke (Rangasamy et al., 2004; Iizuka
t al., 2005; Müller and Hengstermann, 2012). The role of NRF2
n the vasculature is less clear; modest activation by physiological
aminar ﬂow is thought to protect endothelial cells from oxida-
ive stress (Zakkar et al., 2009). However, when crossed with a
yperlipidaemic mouse, the Nrf2 knockout mouse develops less
therosclerosis, suggesting NRF2 activation contributes to disease
rogression (Barajas et al., 2011). The upregulation of cytochrome
450 family members by cigarette smoke has also been reported
reviously, indicating they are another biomarker of toxic com-
ounds found in cigarette smoke (Baker et al., 2001; Zevin and
enowitz, 1999).
We  investigated the biological response to e-cigarette aerosol
xposure and conventional cigarette smoke exposure at the cellular
evel, by exposing primary human coronary artery endothelial cellsocytochemistry 2 h after a single treatment. CSE induced a shift in localisation to a
tom row of panel B). Error bars represent the SEM. Numerical results are shown in
to aqueous ﬁltered extracts of aerosol or smoke and measuring gene
expression changes consistent with a stress response.
2. Methods
2.1. Generation of cigarette smoke extract and electronic
cigarette aerosol extract
Cigarette smoke extract (CSE) was  created using mainstream
smoke from a single Marlboro Gold cigarette (7 mg  tar, 0.6 mg nico-
tine) drawn through 10 ml  of endothelial cell growth media MV2
(Promocell, C-22120) at a rate of 70 ml/min. Under these condi-
tions, the cigarette was consumed in ∼5.5 min resulting in ∼385 ml
of mainstream smoke being drawn through the solution. Electronic
cigarette aerosol extract (eCAE) was  created using the same appa-
ratus, using an iStick battery at constant power output (10.8 W,
4.2 V), with an Aerotank Mini atomiser (1.8 )  loaded with Haven
ﬂuid USA Mix  18 mg/ml  nicotine solution (80% vegetable glycerine,
20% propylene glycol). eCAE was  generated using 5 cycles of 5 s
heat with at least 10 s in between each puff to allow the coil to cool,
with air being drawn through the device at 70 ml/min. A visible
vapour was  generated using these conditions. A fresh pre-soaked
heating coil was  used for each experiment. A higher power output
was selected for generation of eCAE as it has been shown that the
levels of potentially harmful chemicals produced by e-cigarettes
258 J.E. Teasdale et al. / Drug and Alcohol Dependence 163 (2016) 256–260
Fig. 2. Changes in gene expression in interleukin 8, neuronal pentraxin I and cytochrome p450 1A1 and 1B1.
C d cyto
o  0.05 
l wn in
i
2
r
t
t
t
N
L
n
t
3
2
f
t
t
t
m
a
m
c
H
t
g
2
t
(
u
p
a
Khanges in gene expression in interleukin 8 (IL8), neuronal pentraxin I (NPTX1) an
f  CSE (10%), eCAE (10%) or nicotine (350 ng/ml, 2.16 M),  or vehicle control (*P <
ogarithmic scale (base 10). Error bars represent the SEM. Numerical results are sho
ncreases with voltage applied to the heating coil (Kosmider et al.,
014).
CSE and eCAE were ﬁltered using a 0.2 M sterile ﬁlter to
emove any particulate matter (to sterilise the extracts, and also
o simulate the ﬁltering that would occur in the lung), and diluted
o 10% in endothelial cell growth media before being added to
he cell. CSE and eCAE were used immediately after generation.
icotine concentrations in CSE and eCAE were measured by ABS
aboratories Ltd, which indicated that both contained 3.5 g/ml of
icotine; therefore, the diluted solutions applied to the cells con-
ained 350 ng/ml nicotine. Nicotine (Sigma, N3876) was  diluted to
50 ng/ml and used as a control.
.2. Tissue culture
Human coronary artery endothelial cells (HCAEC) from 3 to 6 dif-
erent donors, passage 4–5, were seeded in 6 well plates and grown
o form a conﬂuent monolayer. They then received 3 sequential
reatments of 10% CSE, 10% eCAE, or nicotine (350 ng/ml) 16 h apart,
o study the stable effects of these treatments on cells (see supple-
entary methods and model validation data). Cells were lysed 16 h
fter the last treatment and total RNA isolated using Purelink RNA
ini kit (Ambion, Life technologies) for analysis of gene expression
hanges.
We  independently validated a panel of NRF2-regulated genes in
CAEC using adenoviral overexpression of NRF2 (see Supplemen-
ary Fig. 1) and used this panel of genes to monitor NRF2-regulated
ene expression in response to treatment (Fig. 1A).
.3. Analysis of gene expression
Quantitative PCR (qPCR) was performed on 500 ng reverse
ranscribed total RNA using QuantiTect Reverse Transcription Kit
Qiagen) with LightCycler 480 SYBR Green I Master Mix (Roche)
sing primers listed in Supplementary Table 1. All replicates were
erformed using primary cells from different donors. Statistical
nalyses were performed using a oneway ANOVA with Tukey-
ramer post hoc tests.chrome p450 1A1 and 1B1 (CYP1A1, CYP1B1) exposed to 3 sequential treatments
vs all other treatments, n = 3–6; †P  < 0.05 vs eCAE, n = 3–6). Change is shown on a
 Supplementary Table 2.
2.4. Immunocytochemistry
Immunocytochemistry to detect NRF2 localisation was per-
formed on HCAEC exposed to treatments for 2 h, before being
ﬁxed with 4% paraformaldehyde for 10 min. NRF2 localisation was
detected using rabbit anti-Nrf2 (Santa Cruz SC-722) and cell bound-
aries using mouse anti-catenin (BD 610153).
3. Results
We  selected genes for investigation (SRXN1, DDIT4L,  HMOX1,
GCLM, OSGIN1, PAR4, CYP1A1, CYP1B1) on the basis of literature
searches and previous unpublished work. From these, we selected
six (HMOX1, GCLM,  OSGIN1, PAR4, CYP1A1, CYP1B1) that showed
clear evidence of regulation by CSE, deﬁned as greater that two-
fold relative to control, and compared these to both nicotine and
eCAE.
3.1. CSE but not eCAE activates the oxidative stress pathway
Upregulation of HMOX1, GCLM, OSGIN1 and PAR4 was observed
as following exposure to CSE (P < 0.05 v all other treatments,
n = 3–6), but not by eCAE or nicotine. This suggests NRF2 is acti-
vated by CSE, but not eCAE. Immunocytochemistry was used to
analyse the intracellular location of NRF2. Two-hour exposure to
CSE induced a shift in NRF2 from a predominantly cytoplasmic to
a predominantly nuclear localisation, indicating NRF2 activation
(Fig. 1B).
3.2. CSE but not eCAE increases expression of cytochrome P450,
IL8 and NTPX1
Of the different p450 cytochromes expressed in HCAEC, two
(CYP1A1, CYP1B1) were upregulated by CSE (Fig. 2, P < 0.05 vs
all other treatments, n = 3–6); however, eCAE did not affect gene
expression levels. We  also assessed interleukin 8 (IL8) and neuronal
pentraxin I (NTPX1), because we  have found both to be regulated
by CSE (unpublished data). We  observed that CSE upregulated the
expression of both IL8 and NTPX1,  while eCAE did not. Interest-
ingly, IL8 expression was reduced and NTPX1 increased by nicotine,
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hich were unchanged by eCAE despite equivalent nicotine con-
entrations (P < 0.05 vs eCAE, n = 3–6).
. Discussion
We  explored gene expression changes consistent with a cellular
esponse to perceived xenobiotic stress, activation of the antioxi-
ant response and increases in cytochrome p450, in response to
SE and eCAE. Our results indicate that HCAEC respond to the
oxious components in CSE, resulting in activation of NRF2 and
pregulation of cytochrome p450 (i.e., a stress response). How-
ver, eCAE did not induce NRF2 nuclear localisation, upregulation
f NRF2-activated genes, or the upregulation of cytochrome p450.
L8 directly enhances endothelial cell survival, proliferation, and
atrix metalloproteinases production (Li et al., 2003). NPTX1 is a
ovel epigenetic regulation gene associated with lung cancer prog-
osis (Zhou et al., 2015) that enhances the level of endothelial
poptosis (Guzeloglu-Kayisli et al., 2014). Interestingly, there was
 difference in expression of both of these genes between nicotine
nd eCAE, despite an equal concentration of nicotine in both, sug-
esting that while eCAE does not induce the same stress response
s CSE, there is a biological effect of other constituents of eCAE,
lbeit one that does not reﬂect a stress response in our model.
This study used primary HCAEC because of their involve-
ent in the development of cardiovascular disease (Sima et al.,
009; Gimbrone Jr. and García-Carden˜a, 2013); additionally, we
ttempted to create conditions relevant to this investigation by
ubbling ﬁltered mainstream smoke through tissue culture media,
hich was ﬁltered (0.2 m)  and diluted before being added to cells.
hilst it is not possible to perfectly simulate the mode and systemic
ffects of smoking, CSE contained only the soluble components
f cigarette smoke gas phase and not the tar phase or particu-
ates >0.2 m.  This made conditions more suitable for looking at
he systemic vascular effects of cigarette smoke, as opposed to the
ungs. The use of tissue culture media may  be important as it con-
ains 5% serum. Highly reactive chemical moieties and free radicals
ay  react with and modify the proteins in the media to create
roinﬂammatory adducts, which in turn may  transmit some of the
oxious effect of CSE to the cell, similar to the way these reactants
ay  modify plasma proteins in vivo. The volume of smoke used in
ur model corresponds to roughly half of the smoke inhaled from a
ow tar cigarette (7–8 puffs) by a regular smoker (Djordjevic et al.,
000; Zacny and Stitzer, 1996). eCAE was generated in an identical
anner to CSE, resulting in the same concentration of nicotine in
he extract (3.5 g/ml).
There are some limitations to this study that should be consid-
red. First, we investigated a single e-cigarette product, a single
ell line, and a limited number of outcomes. Therefore, our results
hould be considered preliminary, and their generalizability tested
n future studies across a range of products, ﬂuids, device settings,
ell lines and outcomes. Second, our pufﬁng protocols were not
esigned to directly mimic  real-world smoking or vaping, but to
tandardise nicotine exposure. Future work should apply protocols
hat mimic  real-world behaviour. Third, the constant ﬂow rate used
o produce CSE means that spikes in combustion temperature will
ave been minimal. These spikes, generated by pufﬁng, generate
arge yields of combustion products, meaning the effects of CSE we
bserved may  in fact be conservative. Fourth, we only examined the
ffects of CSE and eCAE separately. Given that dual-use of conven-
ional cigarettes and e-cigarettes is common, future models should
est different combinations of exposure.Our results suggest that the use of e-cigarettes as a substi-
ute for conventional cigarettes is likely to reduce immediate
obacco-related cardiovascular harms. The absence of NRF2 activa-
ion or upregulation of cytochrome p450 in HCAEC suggests a lowerependence 163 (2016) 256–260 259
biological impact of eCAE compared to CSE. This is in agreement
with other studies suggesting a lower potential disease burden
for e-cigarette use compared with conventional cigarettes (Oh and
Kacker, 2014; Goniewicz et al., 2014). In the absence of long-term
prospective data on the health correlates of e-cigarette use, there
is a critical need to valid laboratory models on the relative harms
of e-cigarettes and conventional cigarettes to inform the ongoing
public health debate regarding their use. This study identiﬁes two
biological axes for analysing the components of CSE and eCAE, and
indicates CSE but not eCAE induces a stress response in human cells.
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